Showing 1 of 1 recruiting trials for “B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)”
Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
👨⚕️ Ryan Cassaday, MD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Apr 2026View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →